BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35137449)

  • 1. Amino acid restriction induces a long non-coding RNA UBA6-AS1 to regulate GCN2-mediated integrated stress response in breast cancer.
    Wu YZ; Chen YH; Cheng CT; Ann DK; Kuo CY
    FASEB J; 2022 Mar; 36(3):e22201. PubMed ID: 35137449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid deprivation promotes tumor angiogenesis through the GCN2/ATF4 pathway.
    Wang Y; Ning Y; Alam GN; Jankowski BM; Dong Z; Nör JE; Polverini PJ
    Neoplasia; 2013 Aug; 15(8):989-97. PubMed ID: 23908598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of activating transcription factor 4 in the hepatic response to amino acid depletion by asparaginase.
    Al-Baghdadi RJT; Nikonorova IA; Mirek ET; Wang Y; Park J; Belden WJ; Wek RC; Anthony TG
    Sci Rep; 2017 Apr; 7(1):1272. PubMed ID: 28455513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF-mutated cells activate GCN2-mediated integrated stress response as a cytoprotective mechanism in response to vemurafenib.
    Nagasawa I; Kunimasa K; Tsukahara S; Tomida A
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1491-1497. PubMed ID: 27965097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GCN2- and eIF2α-phosphorylation-independent, but ATF4-dependent, induction of CARE-containing genes in methionine-deficient cells.
    Mazor KM; Stipanuk MH
    Amino Acids; 2016 Dec; 48(12):2831-2842. PubMed ID: 27613409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GZD824 Inhibits GCN2 and Sensitizes Cancer Cells to Amino Acid Starvation Stress.
    Kato Y; Kunimasa K; Takahashi M; Harada A; Nagasawa I; Osawa M; Sugimoto Y; Tomida A
    Mol Pharmacol; 2020 Dec; 98(6):669-676. PubMed ID: 33033108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through alternative Integrated Stress Response pathways compensates for GCN2 loss in a mouse model of soft tissue sarcoma.
    Lehman SL; Ryeom S; Koumenis C
    Sci Rep; 2015 Jun; 5():11781. PubMed ID: 26123823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability.
    Méndez-Lucas A; Hyroššová P; Novellasdemunt L; Viñals F; Perales JC
    J Biol Chem; 2014 Aug; 289(32):22090-102. PubMed ID: 24973213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK7 is a component of the integrated stress response regulating SNAT2 (SLC38A2)/System A adaptation in response to cellular amino acid deprivation.
    Stretton C; Lipina C; Hyde R; Cwiklinski E; Hoffmann TM; Taylor PM; Hundal HS
    Biochim Biophys Acta Mol Cell Res; 2019 Jun; 1866(6):978-991. PubMed ID: 30857869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA UBA6-AS1 Promotes the Malignant Properties of Glioblastoma by Competitively Binding to microRNA-760 and Enhancing Homeobox A2 Expression.
    Cheng F; Liu J; Zhang Y; You Q; Chen B; Cheng J; Deng C
    Cancer Manag Res; 2021; 13():379-392. PubMed ID: 33469379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine restriction activates the integrated stress response in triple-negative breast cancer cells by a GCN2- and PERK-independent mechanism.
    Rajanala SH; Ringquist R; Cryns VL
    Am J Cancer Res; 2019; 9(8):1766-1775. PubMed ID: 31497357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2.
    Ye J; Palm W; Peng M; King B; Lindsten T; Li MO; Koumenis C; Thompson CB
    Genes Dev; 2015 Nov; 29(22):2331-6. PubMed ID: 26543160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.
    Jadaliha M; Gholamalamdari O; Tang W; Zhang Y; Petracovici A; Hao Q; Tariq A; Kim TG; Holton SE; Singh DK; Li XL; Freier SM; Ambs S; Bhargava R; Lal A; Prasanth SG; Ma J; Prasanth KV
    PLoS Genet; 2018 Nov; 14(11):e1007802. PubMed ID: 30496290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.
    Wang Y; Chen Z
    Bioengineered; 2022 Jan; 13(1):178-189. PubMed ID: 34951345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
    Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.